Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Buy
+7,400
New +$275K ﹤0.01% 5202
2025
Q2
Sell
-12,598
Closed -$462K 6245
2025
Q1
$462K Buy
+12,598
New +$530K ﹤0.01% 4863
2024
Q4
Sell
-12,250
Closed -$510K 6372
2024
Q3
$510K Sell
12,250
-31,597
-72% -$1.44M ﹤0.01% 4822
2024
Q2
$1.81M Sell
43,847
-227,695
-84% -$9.99M ﹤0.01% 3610
2024
Q1
$12M Buy
271,542
+252,681
+1,340% +$11.5M 0.01% 2021
2023
Q4
$869K Sell
18,861
-18,861
-50% -$802K ﹤0.01% 4263
2023
Q3
$1.62M Buy
+37,722
New +$1.76M ﹤0.01% 3759
2023
Q1
Sell
-9,431
Closed -$499K 6759
2022
Q4
$499K Buy
+9,431
New +$465K ﹤0.01% 4748
2019
Q2
Sell
-188,611
Closed -$8.14M 4385
2019
Q1
$8.14M Buy
+188,611
New +$7.59M 0.01% 1415

Other funds holding QGEN

Israel Englander's QGEN Position: Q2 2026 in Review

Israel Englander increased its Qiagen (QGEN) stake by 543% in Q2 2026, buying an estimated $121M and bringing the position to 3,845,605 shares worth $150M. The position accounts for 0.05% of the portfolio, ranked #342.

Israel Englander first reported a position in QGEN in Q1 2017 and has held it in 36 quarters since. The position peaked at $226M in Q4 2020. 332 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Israel Englander held 3,845,605 shares of Qiagen worth $150M as of Q2 2026.
  • Israel Englander bought 3,247,768 Qiagen shares in Q2 2026, an estimated $121M.
  • Qiagen made up 0.05% of Israel Englander's portfolio in Q2 2026, its #342 holding.
  • Israel Englander first reported a position in Qiagen in Q1 2017 and has held it in 36 quarters since.
  • Israel Englander's Qiagen position peaked at $226M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.